BXRX
NASDAQ:BXRX
Baudax Bio, Inc.
- Stock
Market Cap
950.33K
Beta: 1.56
PE Ratio
−0.02
PFCF: −0.07
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|
average inventory | 1.49M - | 3.99M 167.97% | 2.50M 37.32% | ||||
average payables | 4.90M - | 1.46M 70.19% | 1.96M 34.20% | 2.56M 30.50% | 2.70M 5.35% | ||
average receivables | 25.50K - | 296.50K 1,062.75% | 438.50K 47.89% | ||||
book value per share | -9.63K - | -10.54K 9.43% | -2.50K 76.25% | -1.11K 55.61% | 241.62 121.74% | -73.02K 30,319.74% | |
capex per share | -198.49 - | -532.39 168.22% | -222.22 58.26% | -47.99 78.40% | -3.71 92.27% | -60.24 1,524.37% | |
capex to depreciation | -17.88 - | -8.72 51.23% | -3.09 64.53% | -0.25 91.91% | -0.07 71.19% | -0.01 87.17% | |
capex to operating cash flow | 0.03 - | 0.06 94.25% | 0.03 48.67% | 0.01 51.09% | 0.00 71.59% | 0.00 82.53% | |
capex to revenue | -1.30 - | -0.19 85.50% | -0.02 91.62% | ||||
cash per share | 2.66K - | 2.28K 14.22% | 290.31 87.26% | 15.84K 5,356.36% | |||
days of inventory on hand | 627.58 - | 746.72 18.98% | |||||
days payables outstanding | 769.83 - | 219.15 71.53% | 204.50 6.68% | ||||
days sales outstanding | 37.76 - | 183.18 385.12% | 96.36 47.40% | ||||
debt to assets | 0.01 - | 0.14 897.72% | 0.16 12.56% | 0.71 343.17% | |||
debt to equity | -0.05 - | -0.66 1,329.22% | 0.65 197.62% | -0.29 145.53% | |||
dividend yield | |||||||
earnings yield | -0.96 - | -1.16 20.60% | -0.28 76.00% | -4.12 1,379.34% | -1.41 65.82% | -77.52K 5,510,080.98% | |
enterprise value | 63.54M - | 63.54M 0% | 47.73M 24.89% | -1.74M 103.64% | 9.42M 642.60% | 1.86M 80.25% | |
enterprise value over ebitda | -1.80 - | -1.13 37.03% | -0.78 31.04% | 0.03 104.18% | -0.20 698.23% | -0.15 24.80% | |
ev to operating cash flow | -1.47 - | -1.06 27.58% | -0.95 10.32% | 0.04 104.13% | -0.19 585.20% | -0.07 64.99% | |
ev to sales | -3.52 - | 8.72 347.69% | 1.47 83.19% | ||||
free cash flow per share | -6.87K - | -9.75K 41.84% | -7.72K 20.84% | -3.36K 56.49% | -903.81 73.08% | -83.77K 9,168.95% | |
free cash flow yield | -0.70 - | -0.99 41.84% | -0.80 19.93% | -2.37 198.07% | -2.95 24.17% | -26.34K 893,566.47% | |
graham net net | -14.69K - | -15.94K 8.56% | -7.97K 50.04% | -3.88K 51.29% | -388.26 89.99% | -86.64K 22,214.46% | |
graham number | 45.19K - | 51.91K 14.88% | 12.32K 76.26% | 12.07K 2.10% | 1.53K 87.31% | 636.41K 41,458.11% | |
income quality | 0.71 - | 0.81 14.50% | 1.54 89.51% | 0.58 62.34% | 2.49 330.48% | 0.47 81.03% | |
intangibles to total assets | 0.87 - | 0.81 6.46% | 0.53 35.40% | 0.38 27.06% | 0.45 16.41% | 0.21 52.55% | |
interest coverage | -55.03 - | -8.25 85.00% | -2.70 67.33% | ||||
interest debt per share | 115.75 - | 836.43 622.59% | 197.92 76.34% | 84.91K 42,798.46% | |||
inventory turnover | 0.58 - | 0.49 15.95% | |||||
invested capital | -0.05 - | -0.66 1,329.22% | 0.65 197.62% | -0.29 145.53% | |||
market cap | 63.54M - | 63.54M 0% | 64.70M 1.81% | 18.83M 70.90% | 16.78M 10.86% | 1.06K 99.99% | |
net current asset value | -92.75M - | -100.86M 8.74% | -50.80M 49.63% | -46.81M 7.84% | -16.56M 64.63% | -27.93M 68.67% | |
net debt to ebitda | 0.28 - | 0.39 39.28% | 0.15 60.54% | -0.15 196.21% | |||
net income per share | -9.42K - | -11.36K 20.60% | -2.70K 76.27% | -5.82K 115.92% | -431.36 92.59% | -246.53K 57,050.61% | |
operating cash flow per share | -6.67K - | -9.22K 38.08% | -7.49K 18.68% | -3.31K 55.85% | -900.11 72.80% | -83.71K 9,200.44% | |
payables turnover | 0.47 - | 1.67 251.28% | 1.78 7.16% | ||||
receivables turnover | 9.67 - | 1.99 79.39% | 3.79 90.10% | ||||
research and ddevelopement to revenue | 18.43 - | 2.89 84.30% | 3.06 5.86% | ||||
return on tangible assets | -14.43 - | -11.34 21.39% | -0.70 93.82% | -1.83 161.10% | -0.80 56.22% | -10.35 1,192.34% | |
revenue per share | 37.03 - | 19.73 46.71% | 3.82K 19,272.64% | ||||
roe | 0.98 - | 1.08 10.21% | 1.08 0.11% | 5.24 386.42% | -1.79 134.09% | 3.38 289.12% | |
roic | 1.18 - | 1.07 9.28% | 1.18 10.33% | 17.33 1,362.49% | -1.04 106.02% | 4.62 542.68% | |
sales general and administrative to revenue | 11.59 - | ||||||
shareholders equity per share | -9.63K - | -10.54K 9.43% | -2.50K 76.25% | -1.11K 55.61% | 241.62 121.74% | -73.02K 30,319.74% | |
stock based compensation to revenue | 18.95 - | 4.43 76.60% | 1.10 75.10% | ||||
tangible asset value | -90.98M - | -96.87M 6.47% | -45.25M 53.29% | -41.18M 8.99% | -10.58M 74.31% | -26.37M 149.26% | |
tangible book value per share | -14.03K - | -14.94K 6.47% | -6.78K 54.65% | -3.09K 54.36% | -193.27 93.75% | -79.42K 40,996.03% | |
working capital | -42.28M - | -20.27M 52.07% | 12.42M 161.29% | 18.59M 49.64% | 7.85M 57.78% | -15.11M 292.57% |
All numbers in USD (except ratios and percentages)